This is a place to discuss this blog article which shows an example of a formal assessment of heterogeneity of treatment effect, shows how to use penalized maximum likelihood estimation to get patient-specific efficacy estimates, and discusses odds ratios, absolute risk differences, and risk ratios.

This topic is also the place to discuss this blog article which shows how personalization of efficacy estimates can result in worse estimates for individuals if HTE is not large.